• Acquisition takes Quotient Clinical into US Market
    Quotient Clinical were awarded a British Private Equity & Venture Capital Association (BVCA) Management Team Award, Dec 2016

News & Views

Acquisition takes Quotient Clinical into US Market

Feb 23 2017

Quotient Clinical an early phase drug development services provider has its operations into the USA through the acquisition of SeaView Research. The acquisition combines Quotient and SeaView’s complementary customer portfolios and strengthens the early phase clinical experience of the combined business, enabling the company to deliver a broader set of services.

SeaView, an expert clinical pharmacology business founded in 1995, has 160 employees across two clinical pharmacology units located in Miami and Jacksonville, Florida, and a combined bed capacity of 320. Each of the two facilities is capable of undertaking complex clinical research studies including first-in-human investigations.

Mark Egerton, Chief Executive Officer, Quotient, said: “Establishing an operational footprint in the US is an important milestone in the development of our business. We can now offer our customers the option to undertake their early phase clinical research either in the UK or the USA and the acquisition of SeaView is a key component of our plan to replicate our Translational Pharmaceutics platform in the USA.”

Quotient’s proprietary and unique Translational Pharmaceutics platform integrates clinical testing with formulation development and real-time GMP manufacturing.

Harris and Celina Alvarez, co-founders of SeaView, said: “We are excited to join forces with Quotient and are looking forward to working together to continue growing the business. The combination of the Quotient and SeaView businesses enables us to deliver full service support to our customers, and the market potential for Translational Pharmaceutics in the USA is significant.”


Digital Edition

Labmate UK & Ireland 49.2 - March 2024

March 2024

In This Edition Articles - Choosing the right LIMS for your lab: Four key considerations - Pay increases to continue but staff focus on security and training - Building a global culture of...

View all digital editions

Events

Making Pharmaceuticals

Mar 26 2024 Milan, Italy

FORUM LABO LYON

Mar 27 2024 Lyon, France

Microbiology Society Annual Conference 2024

Apr 08 2024 Edinburgh 2024

analytica 2024

Apr 09 2024 Munich, Germany

ChemBio Finland 2024

Apr 10 2024 Helsinki, Finland

View all events